操纵TGF-β信号,以优化宫癌的免疫治疗
Shuping Yin1, Han Cui1, Shuang Qin2
1Department of Obstetrics and Gynecology, Changxing People's Hospital of Zhejiang Huzhou, Changxing 313100, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 30, 2023
概括
转化生长因子-β (TGF-β) 是晚期宫癌的关键分子,促进瘤生长和免疫逃避. 阻断TGF-β有望改善癌症治疗,包括免疫治疗.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 子宫癌对妇女构成全球健康风险.
- 识别分子标对于开发有效的宫癌治疗非常重要.
- 转化生长因子β (TGF-β) 已成为一种潜在的治疗点.
研究的目的:
- 突出TGF-β在晚期宫癌进展中的作用.
- 讨论TGF-β阻断在增强癌症治疗中的潜力.
- 探索针对TGF-β和免疫检查点的新型治疗策略.
主要方法:
- 关于TGF-β在宫癌中的当前科学文献的综述.
- 分析TGF-β在转移,茎状,耐药性和免疫逃避中的参与.
- 检查涉及TGF-β抑制剂和免疫检查点剂的临床研究.
主要成果:
- 在晚期宫癌中,TGF-β积极促进瘤的发展.
- TGF-β阻断在改善治疗结果方面表现出有效性,特别是在免疫治疗中.
- 针对TGF-β和PD-L1的双特异性抗体正在临床研究中.
结论:
- TGF-β是宫癌进展和治疗耐药性的关键调解者.
- 向TGF-β提供了一个有希望的策略,以提高现有的癌症治疗的有效性.
- 未来的宫癌疗法可能涉及对结合TGF-β和免疫检查点抑制的双特异性抗体.
相关概念视频
01:16TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K